Skip to Content Facebook Feature Image

Singapore's MERaLiON, Southeast Asia's empathetic Large Language Model, Breaks New Ground with Multilingual Processing and Emotional Intelligence

Business

Singapore's MERaLiON, Southeast Asia's empathetic Large Language Model, Breaks New Ground with Multilingual Processing and Emotional Intelligence
Business

Business

Singapore's MERaLiON, Southeast Asia's empathetic Large Language Model, Breaks New Ground with Multilingual Processing and Emotional Intelligence

2025-05-29 08:48 Last Updated At:09:05

  • Enhancements to MERaLiON will enable more intuitive and culturally aware AI applications in Southeast Asia and new Consortium with global partners to drive adoption
  • Advancing global conversations through the Digital Ministers Roundtable and mapping of AI Verify Testing Framework and US NIST AI Risk Management Framework
  • New sovereign healthcare agentic AI model, Enigma, sees significant results and partners with industry leaders to accelerate clinical trials and enhance patient care

SINGAPORE, May 29, 2025 /PRNewswire/ -- At ATxSummit 2025, the flagship event of Asia Tech x Singapore (ATxSG), Mrs Josephine Teo, Minister for Digital Development and Information (MDDI), unveiled updates to Singapore's Large Language Model - Multimodal Empathetic Reasoning and Learning in One Network (MERaLiON) - and launched the MERaLiON Consortium, a significant boost to Southeast Asia's AI capabilities. She also announced new global initiatives and collaborations which strengthen Singapore's AI ecosystem and accelerate responsible AI adoption, putting Singapore at the forefront of efforts to operationalise AI safety.

MERaLiON breaks new ground with enhancements and new Global Partnerships

MERaLiON, a large language model developed by A*STAR Institute for Infocomm Research (A*STAR I2R) and supported by IMDA, breaks new ground in regional AI capabilities with enhanced multilingual processing and emotional intelligence. The model now handles Malay, Tamil, Thai, Bahasa Indonesia, and Vietnamese on top of English, Mandarin and Singlish, with advanced code-switching abilities and emotion recognition features. These improvements enable more intuitive and culturally aware AI applications in Southeast Asia, which could be applied to customer service, social service, and marketing. 

To accelerate adoption, IMDA and A*STAR I2R have launched the MERaLiON consortium, to bring together local and global industry players and research and development (R&D) institutions like HTX, MOH Office for Healthcare Transformation (MOHT), NCS, National Supercomputing Centre (NSCC), SPH Media and ST Engineering with technology companies like Axiom IT Solutions, BytePlus, CommonTown, DBS, Grab and Microsoft Singapore. The consortium will focus on developing practical AI applications, from multilingual customer support to health and emotional insight detection and agentic decision-making systems.

Since its release in December 2024, MERaLiON's first version has garnered over 90,000 downloads globally, attracting users from corporate research labs, media service providers, startups, and academics.  

Advancing global conversations for a trusted AI ecosystem 

In the area of AI safety research, Singapore was the site of global cooperation in identifying and prioritising research domains through the "The Singapore Consensus on Global AI Safety Research Priorities" (The Singapore Consensus). This Consensus is a living document that will serve as the foundation for the ATxSG Government-to-Government (G2G) Ministerial Roundtable on Digital Trust which seeks to bridge science to policy, and translate technical research into practical policies, by facilitating meaningful conversations between AI scientists and policymakers.   

Singapore's enhanced AI Verify Testing Framework addresses both Generative AI (Gen AI) and traditional AI risks. In continued collaboration with the US National Institute of Standards and Technology (NIST), we developed a crosswalk to map the enhanced Framework with the NIST AI Risk Management Framework. This reaffirms the alignment between our two countries' AI governance frameworks and reflects our shared commitment to cooperation.  

Together, these initiatives underscore Singapore's commitment to building foundational infrastructure for AI safety development and testing that is grounded in scientific evidence to co-develop implementable, interoperable frameworks for responsible AI.

Strengthening global digital trust partnerships 

Singapore's AI Safety Institute signed a Joint Statement with France's AI Safety Institute to kickstart collaboration and cooperation on AI safety and cooperation on 28 May 2025. The Joint statement was signed between MDDI, Mrs Josephine Teo, and French Minister Delegate of Artificial Intelligence and Digital Technologues, Mrs Clara Chappaz at ATx 2025.

Singapore and US spearhead the Global Cross-Border Privacy Rules (CBPR) Certification for businesses to facilitate trusted cross border data flows, providing access to 9 economies with about 40 trillion in market size. This was developed by the Global CBPR Forum, of which Singapore serves as deputy chair. Companies can apply for the new Certification from 2 June 2025, which will allow organisations to demonstrate compliance with internationally recognised data protection standards.

Singapore's Enigma Health partners with Roche and ST Engineering

Enigma Health, a spinoff from SingHealth Duke-NUS Academic Medical Centre, signed two strategic partnerships on 27 May 2025, with Roche and ST Engineering's Enterprise Digital to expand its capabilities. This was announced by Mdm Rahayu Mahzam, Minister of State for Digital Development and Information at the "Scaling and Sustaining Healthcare with Gen AI" symposium held at ATxSG. These two new partnerships will accelerate clinical trials, market access, insights and business intelligence to help with patients' care and access to novel drugs and digital technologies. 

Enigma Health's flagship product, Enigma, is Singapore's home-grown sovereign healthcare agentic AI platform developed by a team of clinicians and AI scientists to improve workflow optimisation, streamlining data-intensive and time-consuming processes while ensuring robust data security and regulatory compliance. It has been piloted at SingHealth institutions.

Singapore-Thailand alliance strengthens ASEAN's fight against telecom scams 

IMDA and Thailand's National Broadcasting and Telecommunications Commission (NBTC) have signed a Memorandum of Understanding (MoU) to combat telecommunications fraud across ASEAN.

The MOU was exchanged between Ms Jasmin Lau, Minister of State at the Ministry of Digital Development and Information and Dr Sarana Boonbaichaiyapruck, Chairman of the NBTC at the sidelines of ATxSG 2025.  

CONTACT: atxsg.imda@archetype.co 

  • Enhancements to MERaLiON will enable more intuitive and culturally aware AI applications in Southeast Asia and new Consortium with global partners to drive adoption
  • Advancing global conversations through the Digital Ministers Roundtable and mapping of AI Verify Testing Framework and US NIST AI Risk Management Framework
  • New sovereign healthcare agentic AI model, Enigma, sees significant results and partners with industry leaders to accelerate clinical trials and enhance patient care

SINGAPORE, May 29, 2025 /PRNewswire/ -- At ATxSummit 2025, the flagship event of Asia Tech x Singapore (ATxSG), Mrs Josephine Teo, Minister for Digital Development and Information (MDDI), unveiled updates to Singapore's Large Language Model - Multimodal Empathetic Reasoning and Learning in One Network (MERaLiON) - and launched the MERaLiON Consortium, a significant boost to Southeast Asia's AI capabilities. She also announced new global initiatives and collaborations which strengthen Singapore's AI ecosystem and accelerate responsible AI adoption, putting Singapore at the forefront of efforts to operationalise AI safety.

MERaLiON breaks new ground with enhancements and new Global Partnerships

MERaLiON, a large language model developed by A*STAR Institute for Infocomm Research (A*STAR I2R) and supported by IMDA, breaks new ground in regional AI capabilities with enhanced multilingual processing and emotional intelligence. The model now handles Malay, Tamil, Thai, Bahasa Indonesia, and Vietnamese on top of English, Mandarin and Singlish, with advanced code-switching abilities and emotion recognition features. These improvements enable more intuitive and culturally aware AI applications in Southeast Asia, which could be applied to customer service, social service, and marketing. 

To accelerate adoption, IMDA and A*STAR I2R have launched the MERaLiON consortium, to bring together local and global industry players and research and development (R&D) institutions like HTX, MOH Office for Healthcare Transformation (MOHT), NCS, National Supercomputing Centre (NSCC), SPH Media and ST Engineering with technology companies like Axiom IT Solutions, BytePlus, CommonTown, DBS, Grab and Microsoft Singapore. The consortium will focus on developing practical AI applications, from multilingual customer support to health and emotional insight detection and agentic decision-making systems.

Since its release in December 2024, MERaLiON's first version has garnered over 90,000 downloads globally, attracting users from corporate research labs, media service providers, startups, and academics.  

Advancing global conversations for a trusted AI ecosystem 

In the area of AI safety research, Singapore was the site of global cooperation in identifying and prioritising research domains through the "The Singapore Consensus on Global AI Safety Research Priorities" (The Singapore Consensus). This Consensus is a living document that will serve as the foundation for the ATxSG Government-to-Government (G2G) Ministerial Roundtable on Digital Trust which seeks to bridge science to policy, and translate technical research into practical policies, by facilitating meaningful conversations between AI scientists and policymakers.   

Singapore's enhanced AI Verify Testing Framework addresses both Generative AI (Gen AI) and traditional AI risks. In continued collaboration with the US National Institute of Standards and Technology (NIST), we developed a crosswalk to map the enhanced Framework with the NIST AI Risk Management Framework. This reaffirms the alignment between our two countries' AI governance frameworks and reflects our shared commitment to cooperation.  

Together, these initiatives underscore Singapore's commitment to building foundational infrastructure for AI safety development and testing that is grounded in scientific evidence to co-develop implementable, interoperable frameworks for responsible AI.

Strengthening global digital trust partnerships 

Singapore's AI Safety Institute signed a Joint Statement with France's AI Safety Institute to kickstart collaboration and cooperation on AI safety and cooperation on 28 May 2025. The Joint statement was signed between MDDI, Mrs Josephine Teo, and French Minister Delegate of Artificial Intelligence and Digital Technologues, Mrs Clara Chappaz at ATx 2025.

Singapore and US spearhead the Global Cross-Border Privacy Rules (CBPR) Certification for businesses to facilitate trusted cross border data flows, providing access to 9 economies with about 40 trillion in market size. This was developed by the Global CBPR Forum, of which Singapore serves as deputy chair. Companies can apply for the new Certification from 2 June 2025, which will allow organisations to demonstrate compliance with internationally recognised data protection standards.

Singapore's Enigma Health partners with Roche and ST Engineering

Enigma Health, a spinoff from SingHealth Duke-NUS Academic Medical Centre, signed two strategic partnerships on 27 May 2025, with Roche and ST Engineering's Enterprise Digital to expand its capabilities. This was announced by Mdm Rahayu Mahzam, Minister of State for Digital Development and Information at the "Scaling and Sustaining Healthcare with Gen AI" symposium held at ATxSG. These two new partnerships will accelerate clinical trials, market access, insights and business intelligence to help with patients' care and access to novel drugs and digital technologies. 

Enigma Health's flagship product, Enigma, is Singapore's home-grown sovereign healthcare agentic AI platform developed by a team of clinicians and AI scientists to improve workflow optimisation, streamlining data-intensive and time-consuming processes while ensuring robust data security and regulatory compliance. It has been piloted at SingHealth institutions.

Singapore-Thailand alliance strengthens ASEAN's fight against telecom scams 

IMDA and Thailand's National Broadcasting and Telecommunications Commission (NBTC) have signed a Memorandum of Understanding (MoU) to combat telecommunications fraud across ASEAN.

The MOU was exchanged between Ms Jasmin Lau, Minister of State at the Ministry of Digital Development and Information and Dr Sarana Boonbaichaiyapruck, Chairman of the NBTC at the sidelines of ATxSG 2025.  

CONTACT: atxsg.imda@archetype.co 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Singapore's MERaLiON, Southeast Asia's empathetic Large Language Model, Breaks New Ground with Multilingual Processing and Emotional Intelligence

Singapore's MERaLiON, Southeast Asia's empathetic Large Language Model, Breaks New Ground with Multilingual Processing and Emotional Intelligence

TAIPEI, Dec. 31, 2025 /PRNewswire/ -- ARTERY Technology (Cayman) Corporation (Stock Code: 6907; hereinafter referred to as "ARTERY-KY"), a leading designer of 32-bit microcontrollers (MCUs), is scheduled to be listed on the Taipei Exchange (TPEx) under the Semiconductor Industry category in January 2026. The Company held its first pre-IPO investor conference on December 30 (Tuesday) at the Grand Hyatt Taipei, where it presented its competitive strengths and future business outlook to investors.

As a subsidiary of Faraday Technology, ARTERY-KY focuses on the development of high-end 32-bit MCUs. Leveraging ARM® Cortex®-M4 cores with an industry-leading maximum clock speed of up to 288 MHz, the Company delivers exceptional performance. In addition to successfully entering the supply chains of leading global brands, ARTERY-KY has established itself as a key contributor in the China market through localized technical advantages, serving as an important partner in regional supply chain transformation.

ARTERY-KY possesses comprehensive technical capabilities spanning core architecture design to application integration. Its end-market applications cover a wide range of fields, including industrial and motor control, consumer electronics, commercial applications, and vertical industries such as medical, IoT, communications, and automotive electronics. With strengths in high performance, low power consumption, superior integration, and high cost-effectiveness, the Company continues to expand into emerging applications such as drones, robotics, and edge AI, demonstrating strong market competitiveness and growth momentum.

In terms of financial performance, ARTERY-KY recorded revenue of NT$1.635 billion in 2024, representing a year-on-year increase of over 60%, with earnings per share (EPS) of NT$1.67. Revenue for the first three quarters of 2025 reached NT$1.234 billion, maintaining a high level and setting a new historical high for the same period, indicating that the Company has emerged from the inventory adjustment cycle. With continued optimization of its product mix, gross margin rebounded significantly to 33.84%. Net profit after tax for the first three quarters totaled NT$70.52 million, with basic EPS of NT$1.38, marking a 56% year-on-year increase and reflecting solid profitability. As multiple new application projects enter mass production and major customer orders continue to grow steadily, the market expects further optimization of the product portfolio in 2026, driving simultaneous growth in revenue and earnings.

Looking ahead, ARTERY-KY has outlined three major growth strategies. First, it will establish a comprehensive MCU foundation spanning M0 to M85 to build a highly compatible ecosystem. Second, it will expand its ASIC-based customized MCU services to help customers rapidly develop application-specific chips. Finally, the Company will aggressively pursue edge AI opportunities by collaborating with UMC and Faraday Technology, utilizing the most advanced 28-nanometer embedded Flash process to develop an intelligent inference platform. Through a strategy focused on breadth, depth, and forward-looking innovation, ARTERY-KY aims to fully activate its semiconductor growth engine.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Emerging MCU Force ARTERY-KY to Be Listed on TPEx in January 2026, Driving High-Performance Growth Through MCU, Customization, and Edge AI

Emerging MCU Force ARTERY-KY to Be Listed on TPEx in January 2026, Driving High-Performance Growth Through MCU, Customization, and Edge AI

Recommended Articles